Literature DB >> 25557226

Characterization of ghrelin-sensitive neurons in the lumbosacral defecation center in rats.

K Naitou1, T Shiina, R Sugita, H Nakamori, Y Shimizu.   

Abstract

BACKGROUND: Ghrelin is involved in the regulation of somatic growth, feeding behavior and energy homeostasis. Ghrelin stimulates neuropeptide Y (NPY) neurons and activates intracellular AMP-activated protein kinase (AMPK) in the hypothalamus. These NPY neurons also express the leptin receptor and leptin inhibits ghrelin-induced activation of NPY neurons. In the spinal cord, we have demonstrated colokinetic action of ghrelin. However, the precise characteristics of the ghrelin-sensitive neurons remain to be clarified. The aim of this study was firstly to confirm that the action of ghrelin is mediated via a neurogenic pathway in the spinal cord, and secondly to characterize the ghrelin-sensitive neurons by comparing with hypothalamic ghrelin-sensitive neurons.
METHODS: Rats were anesthetised with alpha-chloralose and ketamine, and colorectal intraluminal pressure and expelled volume were recorded in vivo. Drugs were applied intrathecally. KEY
RESULTS: Ghrelin caused enhancement of propulsive contractions. Tetrodotoxin completely blocked the colokinetic effect of ghrelin. An AMPK activator, aminoimidazole carboxamide ribonucleotide, failed to mimic the ghrelin effect. Leptin had no effect on the spontaneous contractions and did not exert a suppressive effect on the ghrelin-enhanced colorectal motility. An NPY Y1 receptor antagonist did not affect the action of ghrelin. NPY had no effect on the colorectal motility. CONCLUSIONS & INFERENCES: This study showed that intrathecal injection of ghrelin stimulates colorectal motility by acting on ghrelin-sensitive neurons in the lumbosacral defecation center. The characteristics of ghrelin-sensitive neurons in the spinal cord are quite different from those of ghrelin-sensitive neurons in the hypothalamus.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  AMPK; NPY; TTX; colorectal motility; in vivo; leptin

Mesh:

Substances:

Year:  2015        PMID: 25557226     DOI: 10.1111/nmo.12492

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

1.  New pharmacological approaches against chronic bowel and bladder problems in paralytics.

Authors:  Pierre A Guertin
Journal:  World J Crit Care Med       Date:  2016-02-04

2.  Colokinetic effect of somatostatin in the spinal defecation center in rats.

Authors:  Kiyotada Naitou; Takahiko Shiina; Hiroyuki Nakamori; Yuuki Sano; Hiroki Shimaoka; Yasutake Shimizu
Journal:  J Physiol Sci       Date:  2017-01-25       Impact factor: 2.781

3.  Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats.

Authors:  Kiyotada Naitou; Hiroyuki Nakamori; Takahiko Shiina; Azusa Ikeda; Yuuta Nozue; Yuuki Sano; Takuya Yokoyama; Yoshio Yamamoto; Akihiro Yamada; Nozomi Akimoto; Hidemasa Furue; Yasutake Shimizu
Journal:  J Physiol       Date:  2016-04-28       Impact factor: 5.182

Review 4.  Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.

Authors:  Gareth J Sanger; John B Furness
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

5.  α-MSH-induced activation of spinal MC1R but not MC4R enhances colorectal motility in anaesthetised rats.

Authors:  Hiromi H Ueda; Kiyotada Naitou; Hiroyuki Nakamori; Kazuhiro Horii; Takahiko Shiina; Tatsunori Masatani; Mitsuya Shiraishi; Yasutake Shimizu
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Colokinetic effect of noradrenaline in the spinal defecation center: implication for motility disorders.

Authors:  Kiyotada Naitou; Takahiko Shiina; Kurumi Kato; Hiroyuki Nakamori; Yuuki Sano; Yasutake Shimizu
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.